WSTAM
Wilbanks Smith & Thomas Asset Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $598K | Sell |
13,950
-274
| -2% | -$11.7K | 0.02% | 320 |
|
|
2023
Q4 | $527K | Sell |
14,224
-825
| -5% | -$30.6K | 0.02% | 328 |
|
|
2023
Q3 | $546K | Sell |
15,049
-29
| -0.2% | -$1.05K | 0.02% | 298 |
|
|
2023
Q2 | $537K | Sell |
15,078
-356
| -2% | -$12.7K | 0.02% | 302 |
|
|
2023
Q1 | $549K | Buy |
15,434
+620
| +4% | +$22.1K | 0.02% | 290 |
|
|
2022
Q4 | $521K | Sell |
14,814
-983
| -6% | -$34.5K | 0.02% | 303 |
|
|
2022
Q3 | $465K | Sell |
15,797
-41,860
| -73% | -$1.23M | 0.02% | 298 |
|
|
2022
Q2 | $2.51M | Buy |
57,657
+3,382
| +6% | +$147K | 0.11% | 135 |
|
|
2022
Q1 | $2.45M | Buy |
54,275
+17,655
| +48% | +$797K | 0.1% | 137 |
|
|
2021
Q4 | $1.62M | Buy |
36,620
+6,738
| +23% | +$297K | 0.06% | 187 |
|
|
2021
Q3 | $1.14M | Buy |
29,882
+2,153
| +8% | +$82.3K | 0.04% | 210 |
|
|
2021
Q2 | $1.1M | Buy |
27,729
+4,458
| +19% | +$177K | 0.04% | 215 |
|
|
2021
Q1 | $831K | Buy |
23,271
+2,414
| +12% | +$86.2K | 0.04% | 229 |
|
|
2020
Q4 | $768K | Sell |
20,857
-215
| -1% | -$7.92K | 0.04% | 218 |
|
|
2020
Q3 | $793K | Sell |
21,072
-119
| -0.6% | -$4.48K | 0.04% | 193 |
|
|
2020
Q2 | $864K | Sell |
21,191
-1,376
| -6% | -$56.1K | 0.05% | 173 |
|
|
2020
Q1 | $855K | Buy |
22,567
+2,606
| +13% | +$98.7K | 0.06% | 168 |
|
|
2019
Q4 | $938K | Buy |
19,961
+4,785
| +32% | +$225K | 0.06% | 180 |
|
|
2019
Q3 | $648K | Sell |
15,176
-522
| -3% | -$22.3K | 0.04% | 195 |
|
|
2019
Q2 | $628K | Buy |
15,698
+1,218
| +8% | +$48.7K | 0.04% | 204 |
|
|
2019
Q1 | $605K | Buy |
14,480
+3,041
| +27% | +$127K | 0.04% | 215 |
|
|
2018
Q4 | $437K | Buy |
11,439
+4,650
| +68% | +$178K | 0.03% | 217 |
|
|
2018
Q3 | $273K | Buy |
+6,789
| New | +$273K | 0.02% | 324 |
|
|
2017
Q4 | – | Sell |
-6,787
| Closed | -$276K | – | 351 |
|
|
2017
Q3 | $276K | Buy |
6,787
+1,514
| +29% | +$61.6K | 0.02% | 262 |
|
|
2017
Q2 | $227K | Sell |
5,273
-1,460
| -22% | -$62.9K | 0.02% | 288 |
|
|
2017
Q1 | $284K | Sell |
6,733
-741
| -10% | -$31.3K | 0.02% | 247 |
|
|
2016
Q4 | $288K | Sell |
7,474
-388
| -5% | -$15K | 0.03% | 236 |
|
|
2016
Q3 | $339K | Buy |
7,862
+186
| +2% | +$8.02K | 0.03% | 204 |
|
|
2016
Q2 | $333K | Sell |
7,676
-334
| -4% | -$14.5K | 0.03% | 207 |
|
|
2016
Q1 | $325K | Sell |
8,010
-65
| -0.8% | -$2.64K | 0.04% | 209 |
|
|
2015
Q4 | $326K | Sell |
8,075
-1,027
| -11% | -$41.5K | 0.03% | 197 |
|
|
2015
Q3 | $350K | Buy |
9,102
+1,102
| +14% | +$42.4K | 0.05% | 182 |
|
|
2015
Q2 | $333K | Sell |
8,000
-1,503
| -16% | -$62.6K | 0.03% | 223 |
|
|
2015
Q1 | $439K | Sell |
9,503
-203
| -2% | -$9.38K | 0.04% | 184 |
|
|
2014
Q4 | $415K | Sell |
9,706
-566
| -6% | -$24.2K | 0.04% | 196 |
|
|
2014
Q3 | $472K | Sell |
10,272
-1,871
| -15% | -$86K | 0.05% | 170 |
|
|
2014
Q2 | $649K | Buy |
12,143
+520
| +4% | +$27.8K | 0.07% | 147 |
|
|
2014
Q1 | $621K | Sell |
11,623
-179
| -2% | -$9.56K | 0.07% | 148 |
|
|
2013
Q4 | $630K | Sell |
11,802
-1,349
| -10% | -$72K | 0.07% | 144 |
|
|
2013
Q3 | $660K | Buy |
13,151
+1,600
| +14% | +$80.3K | 0.09% | 134 |
|
|
2013
Q2 | $577K | Buy |
+11,551
| New | +$577K | 0.09% | 135 |
|